Core Viewpoint - Rosen Law Firm is encouraging investors of Quanex Building Products Corporation to secure legal counsel before the November 18, 2025 deadline for a securities class action lawsuit related to misleading statements made during the Class Period from December 12, 2024, to September 5, 2025 [1][2]. Group 1: Class Action Details - Investors who purchased Quanex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must move the Court by November 18, 2025 [3]. - The lawsuit alleges that Quanex made false and misleading statements regarding its tooling and equipment maintenance, which were significantly underinvested, leading to degraded conditions and potential significant costs [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise in this area [4].

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit on behalf of investors in Primo Brands Corporation and Primo Water Corporation, alleging misrepresentation and failure to disclose key facts regarding the merger between the two companies, which led to investor losses during the specified Class Period [2][6]. Group 1: Class Action Details - The class action lawsuit covers purchasers of common stock of Primo Water Corporation from June 17, 2024, to November 8, 2024, and purchasers of common stock of Primo Brands Corporation from November 11, 2024, to November 6, 2025 [2]. - Investors who purchased securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A lead plaintiff must file a motion with the Court by January 12, 2026, to represent other class members in the litigation [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its success in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5]. - The founding partner, Laurence Rosen, was named a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and recognition in the field [5]. Group 3: Case Specifics - The lawsuit claims that the merger between Primo Water and BlueTriton Brands was misrepresented, with defendants allegedly providing false statements about the merger's progress and expected benefits, leading to investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm is reminding investors of WPP plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to the purchase of American Depositary Shares (ADS) during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased WPP ADSs between February 27, 2025, and July 8, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 8, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The complaint alleges that WPP provided misleading statements about its media arm's capabilities, failing to address significant market share losses and macroeconomic challenges, which led to investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm is reminding investors of Sina Corporation about the upcoming November 18, 2025 deadline to join a securities class action related to the company's merger activities [1][2]. Group 1: Class Action Details - Investors who sold ordinary shares of Sina, particularly during the merger period from October 13, 2020, to March 22, 2021, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by the November 18, 2025 deadline to serve as lead plaintiff, representing other class members [3][6]. - The lawsuit alleges that defendants engaged in a fraudulent scheme to depress the value of Sina's shares, misrepresenting material information necessary for shareholders to make informed decisions regarding the merger [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Specifics - The lawsuit claims that the defendants concealed the true value of Sina's investment in TuSimple, leading to an undervaluation of the shares during the merger, with the offer of $43.30 per share being significantly lower than the actual value [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Jasper Therapeutics, Inc. to secure legal counsel before the November 18, 2025 deadline for a securities class action lawsuit related to the company's alleged misleading statements and failures in manufacturing compliance [1][5]. Group 1: Legal Action Details - Investors who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Jasper Therapeutics - The lawsuit claims that Jasper Therapeutics made false and misleading statements regarding its manufacturing controls and compliance with cGMP regulations, which could negatively impact the clinical and commercial prospects of its products, including briquilimab [5]. - The alleged failures increased the risk of confounding results in ongoing studies and the likelihood of disruptive cost-reduction measures, leading to overstated business and financial prospects [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading statements made by the company during the class period from July 29, 2024, to January 6, 2025 [1][5]. Group 1: Class Action Details - Investors who purchased or sold Cepton common stock during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - The Board of Directors is accused of not adequately exploring the third-party offer and failing to disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company and significant recoveries for investors, totaling over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is urging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline related to a securities class action lawsuit [2][4]. Group 1: Class Action Details - The class action pertains to CarMax securities purchased between June 20, 2025, and November 5, 2025, and aims to address alleged misleading statements made by the company during this period [2][6]. - The lawsuit claims that CarMax's growth prospects were overstated, attributing earlier growth to temporary factors rather than sustainable business practices [6]. Group 2: Legal Representation - Investors can join the class action without incurring out-of-pocket fees through a contingency fee arrangement [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant settlements for investors [5]. Group 3: Next Steps for Investors - Interested investors are encouraged to visit the Rosen Law Firm's website or contact them directly for more information on joining the class action [4][7]. - It is noted that no class has been certified yet, and investors have the option to remain absent or select their own counsel [8].

Core Viewpoint - Metals Creek Resources Corp. has received conditional approval from the TSX Venture Exchange for a non-brokered private placement aimed at raising up to $1,000,000 through the issuance of flow-through and non-flow-through units [1][4]. Financing Details - The company plans to issue up to 12,500,000 flow-through units at a price of $0.04 per unit and up to 14,285,714 non-flow-through units at a price of $0.035 per unit, totaling up to $1,000,000 in proceeds [2]. - Each flow-through unit consists of one flow-through common share and one-half of a non-flow-through common share purchase warrant, with the whole warrant allowing the purchase of one additional common share at an exercise price of $0.06 for 24 months [2]. - Each non-flow-through unit consists of one non-flow-through common share and one non-flow-through common share purchase warrant, with the warrant allowing the purchase of one additional common share at an exercise price of $0.06 for 60 months [2]. Financing Progress - The company has closed the first tranche of the financing, issuing 7,500,000 non-flow-through units and 8,625,000 flow-through units, resulting in gross proceeds of $607,500 [3]. Use of Proceeds - Proceeds from the flow-through units will be allocated for exploration on the company's properties in Newfoundland and Ontario, including the Ogden Gold Project, ensuring that these expenses qualify as "flow-through mining expenditures" under the Income Tax Act (Canada) [5]. Company Overview - Metals Creek Resources Corp. is a junior exploration company incorporated in British Columbia, listed on the TSX Venture Exchange under the symbol "MEK" [6]. - The company holds a 50% interest in the Ogden Gold Property, which includes the past-producing Naybob Gold mine, located 6 km south of Timmins, Ontario [7].

Core Viewpoint - Minnova Corp. has filed an amended and restated offering document for a private placement aiming to raise up to C$5 million to support its PL Gold Mine Project and general corporate purposes [1][4]. Group 1: Offering Details - The Marketed Offering will consist of units priced at C$0.20, flow-through units at C$0.23, and charity flow-through units at C$0.32, with a total offering size of up to C$5 million [2][7]. - Each unit includes one common share and one warrant, with warrants allowing the purchase of additional shares at C$0.30 within 36 months after the closing date [2][3]. - An option has been granted to Red Cloud Securities to sell an additional C$1 million in units prior to the closing of the offering [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to the exploration and advancement of the PL Gold Mine Project, as well as for working capital and general corporate purposes [4]. - Proceeds from the sale of flow-through shares will be used for eligible Canadian exploration expenses related to the PL Gold Mine Project, with all qualifying expenditures renounced in favor of subscribers effective December 31, 2025 [5]. Group 3: Regulatory and Compliance - The offering is subject to regulatory approvals, including from the TSX Venture Exchange, and is scheduled to close on December 3, 2025 [10]. - The securities will be offered in compliance with National Instrument 45-106 and will be freely tradeable in Canada, with restrictions on sales in the United States [8][9]. Group 4: Company Overview - Minnova Corp. is focused on restarting its PL Gold Mine, which has a positive feasibility study indicating an average annual production rate of 46,493 ounces over a minimum five-year mine life [12]. - The project benefits from a short pre-production timeline of 15 months and is located in the Flin Flon Greenstone Belt of Central Manitoba, with existing mining infrastructure nearby [12].

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the lawsuit is from August 6, 2024, to August 4, 2025, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A class action lawsuit has already been filed, and investors wishing to serve as lead plaintiffs must act by January 5, 2026 [4][8]. Group 2: Allegations Against Inspire Medical - The lawsuit alleges that Inspire Medical misrepresented and failed to disclose critical information regarding the Inspire V sleep apnea device, including its market demand and the necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the Inspire V device, resulting in investor damages when the true situation was revealed [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5].